Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis C

  Free Subscription


1 Ann Intern Med
1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
1 J Gastroenterol
1 J Hepatol
1 J Med Virol
1 J Viral Hepat
1 J Virol
1 Lancet
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Intern Med

  1. DURAND CM, Bowring MG, Brown DM, Chattergoon MA, et al
    Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.
    Ann Intern Med. 2018 Mar 6. pii: 2674335. doi: 10.7326/M17-2871.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  2. HU KQ, Cui W
    Persistence of Circulating Hepatitis C Virus Antigens-Specific Immune Complexes in Patients with Resolved HCV Infection.
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-4968.
    PubMed     Text format     Abstract available

    Eur J Gastroenterol Hepatol

  3. KOBAYASHI N, Iijima H, Tada T, Kumada T, et al
    Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
    Eur J Gastroenterol Hepatol. 2018 Feb 28. doi: 10.1097/MEG.0000000000001106.
    PubMed     Text format     Abstract available

  4. VEIGA ZST, Villela-Nogueira CA, Fernandes FF, Cavalcanti MG, et al
    Transient elastography evaluation of hepatic and spleen stiffness in patients with hepatosplenic schistosomiasis.
    Eur J Gastroenterol Hepatol. 2017;29:730-735.
    PubMed     Text format     Abstract available

    J Gastroenterol

  5. AKUTA N, Toyota J, Karino Y, Ikeda F, et al
    Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
    J Gastroenterol. 2018 Mar 2. pii: 10.1007/s00535-018-1445.
    PubMed     Text format     Abstract available

    J Hepatol

  6. PETTA S, Adinolfi LE, Fracanzani AL, Rini F, et al
    Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30132.
    PubMed     Text format     Abstract available

    J Med Virol

  7. ANTONIO UL, Alicia OM, Antonio MJ, Elena GM, et al
    Presence of rare hepatitis C virus subtypes, 2j, 2k and 2r, in Mexico City as identified by sequencing.
    J Med Virol. 2018 Mar 6. doi: 10.1002/jmv.25070.
    PubMed     Text format     Abstract available

    J Viral Hepat

  8. PAPATHEODORIDIS GV, Hatzakis A, Cholongitas E, Baptista-Leite R, et al
    Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    J Viral Hepat. 2018;25 Suppl 1:6-17.
    PubMed     Text format     Abstract available

    J Virol

  9. RIVA L, Song OR, Prentoe J, Helle F, et al
    J Virol. 2018 Feb 28. pii: JVI.01982-17. doi: 10.1128/JVI.01982.
    PubMed     Text format     Abstract available


  10. MOIN A, Fatima H, Qadir TF
    Tackling hepatitis C-Pakistan's road to success.
    Lancet. 2018;391:834-835.
    PubMed     Text format    

    PLoS One

  11. MAPOURE NY, Budzi MN, Eloumou SAFB, Malongue A, et al
    Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study.
    PLoS One. 2018;13:e0192406.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.